Patent · US Active

2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity

US11660303B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignee

Kancera AB · SE

Inventors

Hakan Mellstedt · Stockholm, SE
Styrbjörn Byström · Solna, SE
Jan Vågberg · Sollentuna, SE
Elisabeth Olsson · Sollentuna, SE

Key dates

Filing date	Apr 30, 2021
Grant date	May 30, 2023
Priority date	—
Expiry date	Jun 19, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/5377
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula (I′) or (I″) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of mammalian kinase enzyme activity, including ROR1 tyrosine kinase activity and may be used in the treatment of disorders associated with such activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.